Serena Duchi1,2, Sam L Francis3,4, Carmine Onofrillo3,4, Cathal D O'Connell4,5, Peter Choong3,4,6, Claudia Di Bella3,4,6. 1. Department of Surgery, The University of Melbourne, Melbourne, VIC, Australia. sduchi@unimelb.edu.au. 2. BioFab3D-ACMD-St Vincent's Hospital, Melbourne, VIC, Australia. sduchi@unimelb.edu.au. 3. Department of Surgery, The University of Melbourne, Melbourne, VIC, Australia. 4. BioFab3D-ACMD-St Vincent's Hospital, Melbourne, VIC, Australia. 5. Electrical and Biomedical Engineering, School of Engineering, RMIT University, Melbourne, VIC, Australia. 6. Department of Orthopaedics, St Vincent's Hospital, Melbourne, VIC, Australia.
Abstract
BACKGROUND: Articular cartilage repair using implantable photocrosslinkable hydrogels laden with chondrogenic cells, represents a promising in situ cartilage engineering approach for surgical treatment. The development of a surgical procedure requires a minimal viable product optimized for the clinical scenario. In our previous work we demonstrated how gelatin based photocrosslinkable hydrogels in combination with infrapatellar derived stem cells allow the production of neocartilage in vitro. In this study, we aim to optimize the critical facets of the in situ cartilage engineering therapy: the cell source, the cell isolation methodology, the cell expansion protocol, the cell number, and the delivery approach. METHODS: We evaluated the impact of the critical facets of the cell-laden hydrogel therapy in vitro to define an optimized protocol that was then used in a rabbit model of cartilage repair. We performed cells counting and immunophenotype analyses, chondrogenic potential evaluation via immunostaining and gene expression, extrusion test analysis of the photocrosslinkable hydrogel, and clinical assessment of cartilage repair using macroscopic and microscopic scores. RESULTS: We identified the adipose derived stem cells as the most chondrogenic cells source within the knee joint. We then devised a minimally manipulated stem cell isolation procedure that allows a chondrogenic population to be obtained in only 85 minutes. We found that cell expansion prior to chondrogenesis can be reduced to 5 days after the isolation procedure. We characterized that at least 5 million of cells/ml is needed in the photocrosslinkable hydrogel to successfully trigger the production of neocartilage. The maximum repairable defect was calculated based on the correlation between the number of cells retrievable with the rapid isolation followed by 5-day non-passaged expansion phase, and the minimum chondrogenic concentration in photocrosslinkable hydrogel. We next optimized the delivery parameters of the cell-laden hydrogel therapy. Finally, using the optimized procedure for in situ tissue engineering, we scored superior cartilage repair when compared to the gold standard microfracture approach. CONCLUSION: This study demonstrates the possibility to repair a critical size articular cartilage defect by means of a surgical streamlined procedure with optimized conditions.
BACKGROUND: Articular cartilage repair using implantable photocrosslinkable hydrogels laden with chondrogenic cells, represents a promising in situ cartilage engineering approach for surgical treatment. The development of a surgical procedure requires a minimal viable product optimized for the clinical scenario. In our previous work we demonstrated how gelatin based photocrosslinkable hydrogels in combination with infrapatellar derived stem cells allow the production of neocartilage in vitro. In this study, we aim to optimize the critical facets of the in situ cartilage engineering therapy: the cell source, the cell isolation methodology, the cell expansion protocol, the cell number, and the delivery approach. METHODS: We evaluated the impact of the critical facets of the cell-laden hydrogel therapy in vitro to define an optimized protocol that was then used in a rabbit model of cartilage repair. We performed cells counting and immunophenotype analyses, chondrogenic potential evaluation via immunostaining and gene expression, extrusion test analysis of the photocrosslinkable hydrogel, and clinical assessment of cartilage repair using macroscopic and microscopic scores. RESULTS: We identified the adipose derived stem cells as the most chondrogenic cells source within the knee joint. We then devised a minimally manipulated stem cell isolation procedure that allows a chondrogenic population to be obtained in only 85 minutes. We found that cell expansion prior to chondrogenesis can be reduced to 5 days after the isolation procedure. We characterized that at least 5 million of cells/ml is needed in the photocrosslinkable hydrogel to successfully trigger the production of neocartilage. The maximum repairable defect was calculated based on the correlation between the number of cells retrievable with the rapid isolation followed by 5-day non-passaged expansion phase, and the minimum chondrogenic concentration in photocrosslinkable hydrogel. We next optimized the delivery parameters of the cell-laden hydrogel therapy. Finally, using the optimized procedure for in situ tissue engineering, we scored superior cartilage repair when compared to the gold standard microfracture approach. CONCLUSION: This study demonstrates the possibility to repair a critical size articular cartilage defect by means of a surgical streamlined procedure with optimized conditions.
Authors: Andrew C Daly; Fiona E Freeman; Tomas Gonzalez-Fernandez; Susan E Critchley; Jessica Nulty; Daniel J Kelly Journal: Adv Healthc Mater Date: 2017-08-14 Impact factor: 9.933
Authors: Brian Johnstone; Mauro Alini; Magali Cucchiarini; George R Dodge; David Eglin; Farshid Guilak; Henning Madry; Alvaro Mata; Robert L Mauck; Carlos E Semino; Martin J Stoddart Journal: Eur Cell Mater Date: 2013-05-02 Impact factor: 3.942
Authors: Ken Ye; Raed Felimban; Kathy Traianedes; Simon E Moulton; Gordon G Wallace; Johnson Chung; Anita Quigley; Peter F M Choong; Damian E Myers Journal: PLoS One Date: 2014-06-11 Impact factor: 3.240